Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists.
about
Hypoxia: The Force that Drives Chronic Kidney DiseaseTubulointerstitial injury and the progression of chronic kidney diseaseFGF23 signaling impairs neutrophil recruitment and host defense during CKD.Stop chronic kidney disease progression: Time is approachingSUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cellsLeukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal miceCCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.Targeting of the immune system in systemic lupus erythematosus.Low oxygen stimulates the immune system.Circulating chemokine ligand levels before and after successful kidney transplantationTargeting chemokines in proteinuria-induced renal disease.Danger control programs cause tissue injury and remodeling.Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis.Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes.Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing.The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.Association between Mitochondrial DNA Copy Number in Peripheral Blood and Incident CKD in the Atherosclerosis Risk in Communities Study.Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?FGF23 Actions on Target Tissues-With and Without Klotho.
P2860
Q26768865-3460B6A7-ECA5-4AA6-B46A-C8CF837C0B8DQ26852862-9CC5AEE2-DAF6-4AA6-9DDA-09662DFEFE9DQ27330325-939A912F-A447-402B-A220-CFC40275128EQ28078020-7C4EB52F-8EAD-43E0-A404-07200A1DF835Q35048727-42CC5B44-7C66-48D1-96DB-0A39A6D532D4Q35963225-357778C4-BDBE-4112-BDFA-1840DB68FB6DQ36384883-34920189-A142-4F13-A75E-E03F880819E0Q37060593-8AD93B92-218B-4E01-99D6-0250D5ABFF2EQ37217261-61321534-38D8-4755-8FCF-657EB483C522Q37369596-9F9B1301-5725-4ADA-B5BE-12244EAC3628Q38026076-3F5EE4FE-EDD2-40CA-BB60-65FD7C282EBDQ38113929-DB02BBCE-254D-439A-8C3B-D95D667833A8Q38692356-BA6151A7-8895-4C2A-9665-9EDECAD9AF21Q38834435-9EDAC042-702F-425A-B1FC-895C51C186D7Q38961965-00281218-3015-4435-AF25-15FE377994E9Q39603954-E76E5B61-67D7-426A-84F0-6394D99C19BBQ40153047-74063FF4-4839-4663-A062-9622509F7410Q40271425-69FEE00E-AB51-4C66-A2B4-873B9F245737Q40960238-D92FB6E2-C9D2-4486-A609-9A7B3761984EQ43293883-6305F9E1-170C-4F00-B343-B1A8200AB90CQ54960612-A263231D-145E-42B5-9BE0-2CDCA84A593E
P2860
Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@ast
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@en
type
label
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@ast
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@en
prefLabel
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@ast
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@en
P2093
P356
P1433
P1476
Progression of kidney disease: ...... ine receptor CCR1 antagonists.
@en
P2093
Ninichuk V
Schlöndorff D
P2888
P356
10.1038/SJ.KI.5000053
P407
P577
2006-01-01T00:00:00Z
P5875
P6179
1038792412